Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome

por Boxer, G, Stuart-Smith, S, Flynn, A, Green, A, Begent, R
Publicado 1999

Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus.

por Fisher, R. A., Paradinas, F. J., Newlands, E. S., Boxer, G. M.
Publicado 1992

Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.

por Boxer, G. M., Abassi, A. M., Pedley, R. B., Begent, R. H.
Publicado 1994

Immunohistological distribution of 5T4 antigen in normal and malignant tissues.

por Southall, P. J., Boxer, G. M., Bagshawe, K. D., Hole, N., Bromley, M., Stern, P. L.
Publicado 1990

Mapping epitope characteristics on carcinoembryonic antigen.

por Harwood, P. J., Britton, D. W., Southall, P. J., Boxer, G. M., Rawlins, G., Rogers, G. T.
Publicado 1986

Urinary gonadotrophin peptide--isolation and purification, and its immunohistochemical distribution in normal and neoplastic tissues.

por Kardana, A., Taylor, M. E., Southall, P. J., Boxer, G. M., Rowan, A. J., Bagshawe, K. D.
Publicado 1988

The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.

por Pedley, R. B., Boden, J. A., Boden, R. W., Green, A., Boxer, G. M., Bagshawe, K. D.
Publicado 1989

Texture analysis of (125)I-A5B7 anti-CEA antibody SPECT differentiates metastatic colorectal cancer model phenotypes and anti-vascular therapy response

por Rajkumar, V, Goh, V, Siddique, M, Robson, M, Boxer, G, Pedley, R B, Cook, G J R
Publicado 2015

Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancer.

por Ornadel, D., Ledermann, J. A., Eagle, K., Pedley, R. B., Boxer, G., Ward, S. E., Olabiran, Y., Bomanji, J.
Publicado 1998

A cytotoxic DNA precursor is taken up selectively by human cancer xenografts.

por Bagshawe, K. D., Boden, J., Boxer, G. M., Britton, D. W., Green, A., Partridge, T., Pedley, B., Sharma, S., Southall, P.
Publicado 1987

The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.

por Olabiran, Y., Ledermann, J. A., Marston, N. J., Boxer, G. M., Hicks, R., Souhami, R. L., Spiro, S. G., Stahel, R. A.
Publicado 1994

Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetry.

por Pedley, R. B., Boxer, G. M., Boden, J. A., Southall, P. J., Begent, R. H., Bagshawe, K. D., Humm, J., Searle, F.
Publicado 1990

Comparison of anti-fetal colonic microvillus and anti-CEA antibodies in peroperative radioimmunolocalisation of colorectal cancer.

por Blair, S. D., Theodorou, N. A., Begent, R. H., Dawson, P. M., Salmon, M., Riggs, S., Kelly, A., Boxer, G., Southall, P., Gregory, P.
Publicado 1990

Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma--implications for radioimmunotherapy.

por Boxer, G. M., Begent, R. H., Kelly, A. M., Southall, P. J., Blair, S. B., Theodorou, N. A., Dawson, P. M., Ledermann, J. A.
Publicado 1992

Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models

por El-Emir, E, Dearling, J L J, Huhalov, A, Robson, M P, Boxer, G, Neri, D, van Dongen, G A M S, Trachsel, E, Begent, R H J, Pedley, R B
Publicado 2007

Clinical Applications of Phage-Derived sFvs and sFv Fusion Proteins

por Chester, K. A., Bhatia, J., Boxer, G., Cooke, S. P., Flynn, A. A., Huhalov, A., Mayer, A., Pedley, R. B., Robson, L., Sharma, S. K., Spencer, D. I. R., Begent, R. H. J.
Publicado 2000